newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Reports Second Quarter 2022 Financial Results

AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2022. Liquidity and Capital Resources During